Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Share News (PRTC)

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 237.50
Bid: 237.50
Ask: 238.50
Change: 3.50 (1.50%)
Spread: 1.00 (0.421%)
Open: 233.00
High: 238.50
Low: 230.50
Prev. Close: 234.00
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: PureTech Health's Akili secures USD160 million in financing

Wed, 26th May 2021 18:03

PureTech Health PLC - clinical-stage biotherapeutics company - Notes investee Akili Interactive has secured USD160 million of combined equity and debt financing. Says funding will accelerate commercialization of Akili's flagship treatment EndeavorRx, enable expansion of Akili's core technology to treat acute and chronic cognitive disorders, and drive further research and development of new technologies to treat broader range of conditions.

Current stock price: 378.50p

Year-to-date change: down 5.4%

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
9 Dec 2019 12:32

PureTech Health Investee Gelesis Gets USD85 Million For Plenity Launch

PureTech Health Investee Gelesis Gets USD85 Million For Plenity Launch

Read more
9 Dec 2019 09:37

PureTech affiliate Gelesis secures $84.6m in new capital

(Sharecast News) - Biotechnology commercialisation company PureTech Health noted on Monday that its affiliate Gelesis had secured $84.6m (£64.26m) in new capital.

Read more
5 Dec 2019 15:18

PureTech Affiliate Vedanta Gets USD6 Million Grant For VE707 Programme

PureTech Affiliate Vedanta Gets USD6 Million Grant For VE707 Programme

Read more
5 Dec 2019 08:14

PureTech Health affiliate Vedanta Biosciences awarded $5.8m grant

(Sharecast News) - Clinical stage biotechnology company PureTech Health said on Thursday that its affiliate, Vedanta Biosciences, has been awarded a $5.8m grant for its 'VE707' programme, targeting multidrug resistant infections.

Read more
21 Nov 2019 10:49

PureTech Health Investee Karuna Prices USD250 Million Public Offering

PureTech Health Investee Karuna Prices USD250 Million Public Offering

Read more
20 Nov 2019 13:27

Wednesday broker round-up

(Sharecast News) - Burford Capital: Berenberg downgrades to hold with a target price of 810p.

Read more
19 Nov 2019 17:03

LONDON MARKET CLOSE: Pound Lower With Johnson And Corbyn To Square Off

LONDON MARKET CLOSE: Pound Lower With Johnson And Corbyn To Square Off

Read more
19 Nov 2019 12:20

PureTech Health surges on positive Karuna Therapeutics drug trial

(Sharecast News) - PureTech Health surged on Tuesday after US biopharmaceutical company Karuna Therapeutics - in which it owns a 32% stake - said a day earlier that a phase 2 trial of its schizophrenia treatment met its primary endpoint.

Read more
18 Nov 2019 16:58

LONDON MARKET CLOSE: Stocks End Higher Despite US-China Trade Doubts

LONDON MARKET CLOSE: Stocks End Higher Despite US-China Trade Doubts

Read more
18 Nov 2019 11:57

PureTech Health's Unit Reports Positive KarXT Clinical Trial Results

PureTech Health's Unit Reports Positive KarXT Clinical Trial Results

Read more
18 Nov 2019 10:22

UK WINNERS & LOSERS SUMMARY: Consort Medical Rises On Takeover Offer

UK WINNERS & LOSERS SUMMARY: Consort Medical Rises On Takeover Offer

Read more
15 Nov 2019 16:54

LONDON MARKET CLOSE: FTSE 100 Shrugs Off BT Decline Amid Trade Hopes

LONDON MARKET CLOSE: FTSE 100 Shrugs Off BT Decline Amid Trade Hopes

Read more
15 Nov 2019 13:49

PureTech Shares Down As Investee Halts Work After Poor Results

PureTech Shares Down As Investee Halts Work After Poor Results

Read more
5 Nov 2019 14:54

PureTech Reports New Data From Its Immuno-Oncology Programmes

PureTech Reports New Data From Its Immuno-Oncology Programmes

Read more
24 Oct 2019 08:09

PureTech affiliate Sonde Health names David Liu as CEO

(Sharecast News) - Clinical stage biotechnology company PureTech Health announced on Thursday that its affiliate Sonde Health had appointed David Liu as chief executive officer and a member of its board of directors.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.